The role of fine excipient particles in adhesive mixtures for inhalation by Tamadondar, Mohammadreza et al.
The role of fine excipient particles in adhesive mixtures for
inhalation
Downloaded from: https://research.chalmers.se, 2021-08-31 11:49 UTC
Citation for the original published paper (version of record):
Tamadondar, M., Salehi, K., Abrahamsson, P. et al (2021)
The role of fine excipient particles in adhesive mixtures for inhalation
AICHE Journal, 67(5)
http://dx.doi.org/10.1002/aic.17150
N.B. When citing this work, cite the original published paper.
research.chalmers.se offers the possibility of retrieving research publications produced at Chalmers University of Technology.
It covers all kind of research output: articles, dissertations, conference papers, reports etc. since 2004.
research.chalmers.se is administrated and maintained by Chalmers Library
(article starts on next page)
P A R T I C L E T E C HNO LOG Y AND F L U I D I Z A T I ON
The role of fine excipient particles in adhesive mixtures for
inhalation
Mohammad R. Tamadondar1 | Kian Salehi1 | Per Abrahamsson2 |
Anders Rasmuson1
1Department of Chemistry and Chemical
Engineering, Chalmers University of
Technology, Gothenburg, Sweden
2Technical Analysis, Fluid Mechanics, AFRY,
Gothenburg, Sweden
Correspondence
Anders Rasmuson, Department of Chemistry
and Chemical Engineering, Chalmers







Despite the fact that adding fines improve the drug dispersion performance during
inhalation, the scarcity of mechanistic insight into the formulation process, indepen-
dent of the aerosolization, has kept the dispute on the underlying improvement
mechanism open. We therefore simulate ternary formulations (carrier, drug, fines) in
a vibrational cell to explore the mixing mechanism and the effect of particle size and
loading ratio of fines on formulation performance. Results suggest that the buffer
theory is a critical contributory mechanism since it curtails the carrier's collision rate
and, therefore, decreases agglomerate breakage. Consequently, relatively larger drug
aggregates are formed over the carrier, which eventually experiences greater detach-
ment forces. A simple dispersion test is performed to evaluate drug detachment rate
at wall-collision. An excess of cohesive fines, or using larger fines, diminishes the
rotational kinetic energy of coarse particles by lumping them together. This reduces
drug agglomerate breakage and leads to poor mixing.
K E YWORD S
adhesive mixing, agglomerate breakage, discrete element method, fine excipient particles,
ternary formulation
1 | INTRODUCTION
The performance of carrier-based dry powder inhalers (DPIs) can be
significantly enhanced by the inclusion of a small amount of fine
excipient particles into the binary blend of carrier and active pharma-
ceutical drug particles. In vitro measurement of the fine particle dose
(FPD) or the fine particle fraction (FPF) of drug particles that is deliv-
ered by the inhaler is normally used as a major indicator of this
enhancement. Extensive research on the carrier-fine-drug ternary
mixture have shown that fine excipient particles improve the perfor-
mance of DPI formulation to varying extents depending on the excipi-
ent's material, the amount and size of the fine particles, and the
blending sequence of mixture components. A comprehensive review
article compiled by Jones and Price1 contains detailed information on
the examined DPI formulations and the influence of additional fine
particles on FPD and FPF.
An unsettled question on the contribution of fine excipient parti-
cles in the DPI formulation is the underlying mechanisms by which
the performance of carrier-based ternary mixture increases. Initially,
two main theories have been proposed in the literature to address this
question (see Figure 1):
a. The active site theory suggests that carrier surface activity has a
heterogeneous distribution, and fine excipient particles compete
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with drug particles for high-energy binding sites. This competition
forces the drug particles to interact with passive or low energy
sites, which facilitates drug-carrier detachment.2-4
b. The agglomeration theory focuses on the possible formation of
fines-drug aggregates during blending. These agglomerates
are subject to stronger aerodynamic drag forces during aero-
solization than small drug particles, which results in a higher
FPD.5-7
Supporting evidence of the active site theory was extracted by
studying the effect of the blending order of mixture components on
formulation performance. Related research has demonstrated that the
fine particle delivery of a formulation prepared, first, by blending car-
rier and fines and then adding the drug is greater than a formulation
prepared by adding fines after blending carrier and drug particles. It
has been proposed that, in the first mixing scenario, fines have the
advantage of establishing contact with more adhesive sites, while in
the second scenario, the strong binding sites of the carrier are occu-
pied by drug particles instead. As the powder is subjected to aerosoli-
zation, the first mixture releases more drug particles than the second
mixture due to the relative strength of carrier-drug binding forces. A
study by Zeng et al8 has illustrated that, by mixing the components
long enough (from 15 to 60 min), the blending sequence becomes
insignificant, indicating that fines and drug particles continue to redis-
tribute until they reach an equilibrium state over the carrier surface.
The active site theory has been found unsatisfactory, or even
contradictory, in explaining the results of some in vitro performance
tests of ternary carrier-based DPI formulations.1 For instance, Jones
et al9 have shown, using direct measurement of adhesion and cohe-
sion forces between particles, that contrary to the prediction of active
site theory, a more adhesive fine particle does not ensure a larger
FPD. Such experimental observations relate the improvement in DPI
performance to the theory of fines-drug agglomeration. This theory
hypothesizes that once the drug particles have been contained in
agglomerated structures with larger mass, they experience greater
aerodynamic forces and, consequently, liberate easier from the carrier
surface. The agglomeration theory also clarifies additional ambiguities,
including the behavior of FPF with a critical ratio of drug/fine in ter-
nary DPI formulation. Islam et al10 have observed that if this ratio
goes beyond one, the excess of drug particles leads to the formation
of so-called drug multiplets with strong adhesive interactions that
eventually decrease the FPF.
Besides these two major theories, additional mechanisms have
been proposed and supported with empirical evidence to explain the
effect of added fines. One is the so-called fluidization reinforcement
hypothesis,11 which argues that the presence of fines increases the
tensile strength of the powder bulk, and thereby, shifts the minimum
fluidization velocity (MFV) in the inhalation chamber. This phenome-
non intensifies interparticle collisions and enhances the likelihood of
drug-carrier de-agglomeration. Dickhoff et al12 have introduced the
buffer hypothesis, which states that fines act as a buffer between col-
liding carriers and protect drug particles from press-on forces.
According to this theory, the fine particles aid dispersion only if the
fine/drug particle size ratio is above one, as the sheltering effect
depends on this size disparity. The idea that fines promote the disinte-
gration of cohesive drug agglomerates has been also proposed and
discussed by Shalash and Elsayed.13
While these mechanisms appear plausible, they remain as specu-
lations due to the abundance of experimental findings under similar
conditions that support alternative choices. One shortcoming that
leads to such discrepancies in the assessment of DPI performance is
the lack of a mechanistic understanding of ternary mixing, and there-
fore, it is crucial to investigate formulation performance independent
of the aerosolization process (i.e., FPD or FPF). To address this issue,
we performed a numerical simulation of adhesive binary and ternary
mixing in a high-intensity vibrational cell, wherein the primary objec-
tive was to unravel the effect of added fines on the quality of mixture.
The Discrete Element Method (DEM) was used for the simulation of
particle movement to gain fine temporal and spatial resolutions on the
particles. Complex-shaped carriers were mathematically described
using Fourier harmonics,14 which is a novel method to incorporate
irregularity and roughness into a particle's morphology. This method
also allows a non-uniform distribution to be imposed onto carrier sur-
face activity. The adhesive mixing process was explored through anal-
ysis of drug and fine agglomerate breakage, particle contact numbers,
and interparticle adhesion forces.
2 | THEORETICAL CONSIDERATIONS
2.1 | Rough particles in contact
The contact area between two particles is a fundamental factor in
determining adhesion force, and surface asperities can drastically
change this factor. Experimental observations have revealed that the
real contact area for particle interaction is less than 15% of the appar-
ent contact area that is estimated from particle size and physical prop-
erties.15 Since particle surfaces are nominally flat, a proper contact
F IGURE 1 The hypothetical mechanisms by which fine excipient
particles improve DPI formulation performance. The active site theory
suggests the occupation of the carriers' strongest binding sites by fine
excipient particles, and the agglomeration theory supports the idea of
the formation of fine-drug agglomerates during blend preparation
[Color figure can be viewed at wileyonlinelibrary.com]
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model must account for particle roughness. The Greenwood and
Williamson (GW) model is one of the classical approaches for incorpo-
rating surface roughness into the contact mechanism.16 In this
approach, a Gaussian distribution of φ(z) for the asperity height is
assumed, and the probability of contact is expressed as:
prob z> dð Þ=
ð∞
d
φ zð Þdz ð1Þ
where d is the separation distance between the reference planes of
two contiguous surfaces (Figure 2). In combination with the Hertzian
elastic contact theory,17 the GW model results in a solution to the
contact problem of rough surfaces. Moreover, the GW model con-
siders the summit of each asperity as a sphere with a constant curva-
ture that deforms separately under compressive load.
An alternative to the GW model, and other indirect solutions to
rough surfaces in the contact (e.g., the fractal model by Majudamer
and Bhushan18), is to approximate the microscale nature of a rough
surface and explicitly resolve the contact model for each individual
asperity on that surface (Figure 2). The latter method suggests that
the magnitude of contact force depends on the radius of curvature at
the contact point corresponding to each asperity height. This
approach relies, first, on the mathematical definition of surface rough-
ness and, second, on the method to make this definition compatible
with the simulation environment.
2.2 | Particle adhesion force distribution
The morphological variations in the contact zone of contiguous sur-
faces imply a distribution of adhesion force on rough surfaces. Three
types of distributions have been identified with a direct measurement
of adhesion force using the atomic force microscopy (AFM)
technique19:
• Type I: Weibull distribution, which applies to the adhesion of rela-
tively smooth particles to substrates with a narrow distribution of
the asperity radius.
• Type II: bimodal Weibull distribution, which describes the adhesion
between particles and substrates with similar orders of magnitude
of roughness.
• Type III: log-normal distribution, which corresponds to surfaces
with rather broad heterogeneity in asperity size distributions.
AFM measurements at multiple sites on the surface of different
lactose particle samples have shown that the adhesion force exhibits
Type III, that is, log-normal, distribution, and this can be expressed by
the geometric mean force and the geometric standard deviation.20,21
An example of AFM data for a Pharmatose 325 M particle is shown in
Figure 3.20 Results of these measurements also fit the definition of
carrier surface activity by Grasmeijer et al,22 wherein the carrier parti-
cle has a range of surface-free energy and promises different abilities
in retaining drug particles during dispersion. This innate nonuniformity
of adhesion force is an essential element of the ternary DPI formula-
tion, and therefore, the simulation framework must allow for such a
characteristic.
2.3 | Computational framework
The classical soft-sphere discrete element method was used to per-
form the simulation of a particulate system. The contact mechanism
between colliding particles is the core of the DEM integration scheme
and is normally expressed in the form of contact force versus overlap.
This relationship depends on the material properties of the particles,
the sizes of the two particles in contact, and their surface conditions.
Contact force and, consequently, contact torque are used to update
the translational and rotational velocities of particles. The intrinsic
dominance of adhesion between micron-sized particles entails using
an adhesive contact model. Two models, the Johnson-Kendall-Roberts
(JKR) theory23 and the Derjaguin-Muller-Toporov (DMT) theory24 are
common to use in DEM codes. These two models represent opposite
extremes , as described by Maugis,25 and the transition between them











JKR applies if λ > 5 and DMT applies if λ < 0.1. This criterion is
recommended over the Tabor number, as the latter one is argued to
sometimes lead to a poor choice of adhesive model.26 Among all the
possible contacts in the present simulation environment, the λ number
F IGURE 2 (A) Theoretical
scheme of the Greenwood-
Williamson model of a rough
surface in contact with a smooth
surface, and (B) approximating
the microscale nature of the
rough surfaces with spherical
elements in order to explicitly
resolve the contact problem
[Color figure can be viewed at
wileyonlinelibrary.com]
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is the least (around 4) for drug–drug contacts because of the smallest
contact radius and largest effective Young modulus. Based on the
Maugis dimensionless number, the elastic JKR model was chosen as
an apt model for calculating the contact force in the subsequent simu-
lations of this study. Moreover, the validity of the JKR theory in
modeling the adhesive behavior of particles, especially in the context
of pharmaceutical powders used in the inhalation process, is well
established.27-29
In the JKR model, the contact is considered to be adhesive over a
finite area, which is correlated to elastic material properties and parti-
cles surface energy. The dependency of contact area radius (a) to nor-




Fne + 3πΓijR 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
6πΓijRFne + 3πΓijR
 2q  ð3Þ
where only the positive root is allowed for stable equilibrium. According
to the force-contact area relationship of the JKR interaction, in the load-
ing regime and comparing to the common Hertzian contact model,17
Equation (3) will generate a larger contact area due to attractive interac-
tion. As a result of this attraction, a finite contact area occurs even under






According to this theory, the maximum tensile force required to
break a contact depends on the effective radius of curvature and the





This expression is commonly used to describe the magnitude of
the pull-off force measurement in the AFM experiment. The





From a computational point of view, having critical force and
overlap as well as normal overlap can lead to the calculation of con-
tact radius and, eventually, the normal elastic force. The procedure for































2.4 | Generating realistic particles for DEM
While the conventional DEM framework conceives of particles as
smooth spherical elements, such ideal morphological features are
a rarity in the common carrier particles used in DPI formulations.
Therefore, a non-spherical scheme must be applied for the simu-
lation of an adhesive ternary system to account for the shape
irregularity and surface roughness of particles. To meet this
requirement, the multisphere model, introduced by Favier et al,30
was selected for creating complex-shaped particles. In this
model, the particle is represented by overlapping spheres, fixed
rigidly with respect to a local coordinate system. Since contact
detection remains sphere-based, this model offers the least com-
plexity in defining a contact plane, particle overlap, and frictional
forces.
A prior step to creating a particle with a multisphere model is
to define the shape outline. In this study, the Fourier-based
method for creating realistic granular samples developed by
Mollon and Zhao31 was used. Initially, the original shape of a parti-
cle is quantified using the closed-form Fourier series to obtain the
spectrum of Fourier shape descriptors.32 This mathematical defini-
tion leads to a series of spatial points that describe the particle
outline, and ultimately, a tessellated surface of particle convex-hull
is generated. Once the particle outline has been generated, it is
replaced with an equivalent collection of overlapping spheres for
future DEM simulation. The mathematical algorithm to achieve a
multisphere model from the 3D convex-hull is commonly known as
an Overlapping Discrete Element Cluster (ODEC). The 3D ODEC
algorithm proposed by Ferellec and McDowell33 was selected as
the basis of the present study. In this algorithm, an arbitrary point
is chosen on the surface of convex-hull, then a sphere is grown
along its internal normal direction and is expanded until it reaches
another point on the surface of the particle. This procedure con-
tinues until there is one sphere for each point. The accuracy of the
shape approximation of the multisphere model is improved by
increasing the resolution of surface discretization as well as intro-
ducing more spheres, each with a small radius. Complex-shaped
F IGURE 3 The adhesion force distribution of 325 M lactose
particles shows that the data follows a log-normal distribution, with a
regression coefficient of 0.99 (Louey et al. 7).
Source: Reprinted with permission from Elsevier
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particles have been created with this method in earlier works by
the authors, wherein the effect of the target particle shape on the
breakage and adhesion pattern of a colliding agglomerate was
investigated.34
3 | SIMULATION SETUP
3.1 | Coarse particle
An integral feature of DEM with a multisphere model is that it allows
the local contact properties of a single particle to be manipulated,
including the radius of curvature. This feature allows the creation of a
particle with a targeted distribution of surface adhesion force, for
example, log-normal distribution. For this purpose, a series of Fourier
shape descriptors are obtained from real particle shapes, and their
corresponding coarse carrier particles are generated in the simulation
domain. Once the carrier particle has been generated, the adhesion
force distribution can be extracted based on the following steps:
1. A virtual spherical domain is created around the carrier particle,
wherein 2000 adhesive micronized particles are randomly inserted.
2. The adhesive particles are gradually dragged toward the carrier
surface by minute-scale impetus force until the contact is stab-
lishes and the kinetic energy of the particles entirely dissipates.
3. The magnitude of the adhesion force between the carrier and small
particles is obtained and turned into a dimensionless quantity by
using the corresponding minimum and maximum values. In this
way, the non-dimensional adhesion force distribution becomes a
unique feature of a coarse carrier particle.
The distribution of the dimensionless adhesion force was exam-
ined, and the carrier with the closest fit to the log-normal distribution
was selected for the purpose of this study. Figure 4 shows the
selected carrier with 2000 adhesive particles of 2 μm diameter depos-
ited over its surface as well as the corresponding distribution of non-
dimensional adhesion force. One can discern a deviation from log-
normal on the left side of the distribution plot, which corresponds to
low values of adhesion force, or equivalently, the small spherical ele-
ments that assemble the carrier particle. While this deviation suggests
that the small spheres must be excluded for a better fit, the adequacy
of shape approximation is dependent on these elements. Therefore,
despite the observed deviation, the simulations were conducted with
this carrier, as it maintained a balance between distribution fitness
and shape approximation adequacy. These simulations were carried
out in LIGGGHTS, open-source DEM particle simulation software.35
The material properties of the carrier were selected based on the lac-
tose particles commonly used in DPI formulation and are presented in
Table 1.
3.2 | Drug particle
Since the natural cohesion of drug particles causes them to aggre-
gate, it is essential to introduce these particles in the correct initial
(b)(a)F IGURE 4 (A) The carrier particle is
coated with 2000 μm-sized adhesive
particles to calculate contact force and
extract surface activity. (B) Distribution
of the non-dimensional adhesion force
of the selected carrier [Color figure can
be viewed at wileyonlinelibrary.com]
TABLE 1 Physical properties of the particles and other simulation
settings
Particle properties Carrier Fine Drug
Particle size (μm) 80a 5b 3
Number of particles 3 700b 900
Particle density36,37 (kg/m3) 1,550 1,550 1,330
Young modulus38 (GPa) 0.1 0.1 2
Poisson ratio39 (−) 0.29 0.29 0.3
Surface energy27 (J/m2) 0.005 0.008 0.015
Friction coefficient40,41 (−) 0.3 0.5 0.26
Rolling friction coefficient42 (−) 0.002 0.002 0.002
Simulation settings
Time step (s) 4 × 10−9
Process time (s) 0.5
Vibration frequency (Hz) 120
Vibration amplitude (μm) 200
Box size (μm) 180 × 180 × 180
aThe average volumetric size is reported here.
bThese numbers correspond to the basic ternary formulation.
TAMADONDAR ET AL. 5 of 13
state into the simulation domain. In order to mimic drug agglomera-
tion, the primary particles were randomly generated in a small con-
fined space and settled under gravitational force until they establish
cohesive contact, and a stable agglomerate has been formed
(i.e., particle kinetic energy has been dissipated). Figure 5A shows
an example of the drug agglomerate with 100 constituent particles
colored by their coordination number. Mono-sized salbutamol sul-
fate (SS), as the most frequently investigated drug particle in DPI
formulation, was used to resemble the active pharmaceutical parti-
cle in the current simulations. The surface energy of drug particle
was extracted using Equation (5) and the available AFM data on the
pull-off force between SS-probe and SS-substrate.27 A total of
900 drug particles, equal to a 1.32% w/w mass loading ratio, were
added to the formulation. The average volumetric size of a drug
agglomerate and its packing fraction were initially 20 μm and 35%,
respectively.
3.3 | Fine particle
The third component in a simulation of the adhesive mixing process is
fine excipient particles. Jones and Price1 have reported that the con-
ventional practice in the preparation of ternary DPI formulation is to
add fine lactose particles with a volume median diameter of (4–7) μm
and proportion in the range of 1.5%–10%. For the current simulations,
700 spherical lactose particles with a diameter of 5 μm (equivalent to
the loading ratio of 5.7% w/w) were included in the system. Because
excipient particles are heavier and less cohesive than drug particles,
the fine particles were introduced individually, that is, in non-
agglomerated form. However, since these particles have a natural
tendency to cluster, they stuck together after being generated in the
simulation environment. The physical and mechanical properties of
fine lactose particles are shown in Table 1.
It is important to mention that in the absence of in-house mea-
surement of material properties, literature data were used to obtain
particles properties. It is acknowledged that finding the correct mate-
rial properties for pharmaceutical particles can be an arduous task.
These data are sometimes reported to fall within a wide range of
values (e.g., the Young modulus of lactose particles) or are rare to find
(e.g., the rolling friction coefficient for salbutamol sulfate). In such
cases, the corresponding values were adopted from calibrated simula-
tion works.
F IGURE 5 (A) Initial state of a
drug agglomerate made of
100 primary particles. (B) A snapshot
of particles before and after ternary
mixing. (C) A snapshot of particles
before and after binary mixing
[Color figure can be viewed at
wileyonlinelibrary.com]
F IGURE 6 Temporal decay in the average coordinate number of
drug particles for ternary and binary systems. The coordination
number is normalized after dividing by the maximum value
(corresponding to intact agglomerates) [Color figure can be viewed at
wileyonlinelibrary.com]
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3.4 | Mixing process
The particles were put into the simulation domain by placing the car-
riers, the fines, and the agglomerates of drug particles in the mixing
cell, respectively (Figure 5(B)). In order to avoid heavy computation,
the mixer contains only three carrier particles. While it deems neces-
sary to simulate ternary formulations at much larger scale, increasing
the number of carriers changes the simulation time drastically not only
because the number of spheres in each carrier increases, but also
more drug and fine particles are required to keep the loading ratios
constant. Sensitivity analysis revealed that increasing the number of
carriers to five does not influence the mixing behavior significantly.
The adhesive mixing process was commenced by inducing high-
intensity vibration to the cuboidal vessel that contained the particles.
The container was vibrated at a preset amplitude and frequency along
the z, y, and x directions. This three-dimensional vibration ensures that
kinetic energy is properly transferred to all the particles, and thus, it
accelerates the mixing process. To emphasize how the ternary system
is different from the binary system, the adhesive mixing of carrier and
drug particles, exclusively, was simulated under similar conditions, and
the outcomes were compared (Figure 5(C)). The total process time
was 0.5 s, which was adequate for this small system of particles. This
adequacy was determined by the pseudo steady-state condition in
coordination number and kinetic energy of drug and fine particles (see
the Appendix S1). After the simulation was completed, the vibration
was stopped, and the particles settled inside the container. The vibra-
tional mixing of carrier and drug particles has been simulated in this
manner in previous studies to investigate the adhesive mixing pro-
cess.43,44 In the present study, simulations of the mixing process were
performed using EDEM commercial software, provided by DEM
Solutions Ltd.
4 | RESULTS AND DISCUSSION
To unravel the role of fine excipient particles, the evolution of mixing
was scrutinized by examining the breakage of agglomerates of fines
and drugs, the deposition of particles over coarse carriers, the
strength of adhesive forces, and the structure of attached layers. Both
binary (without fines) and ternary (with fines) mixtures were analyzed
to pinpoint the mechanistic effects of the fine particles.
4.1 | Breakage of agglomerates
The rate of drug agglomerate breakage was examined by studying the
temporal decay in the average coordination number of these particles.
The coordination number was extracted at each time step and was
(a) (b)
F IGURE 7 (A) Variation of total contact number for fine particles. The inner graph shows the size distribution of fines clusters at t = 0.053 s,
wherein the cluster size is expressed in terms of number of primary particles. (B) Fine particles are colored by coordination number at t = 0.053 s,
where the contact number is the largest (the single fines are excluded) [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 8 Temporal deposition of drug particles over carrier
particles for binary and ternary systems. The value is normalized by
the total number of available drug particles. Only the drug particles
with direct contact to the carriers are counted (red: fines, yellow: drug
with direct contact, white: drug with indirect contact) [Color figure
can be viewed at wileyonlinelibrary.com]
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normalized by dividing by its maximum value, which was obtained
from the initial agglomerate condition. Figure 6 displays the normal-
ized drug coordination number for both binary and ternary mixtures
over time and marks the disparity in agglomerate breakage for these
two systems. Even though both systems were mixed under similar
conditions, the inclusion of fine excipient particles hindered agglomer-
ate breakage.
Besides the rate of drug agglomerate breakage, it is of interest to
study the evolution of clusters of fine excipient particles during
mixing. Although the primary fine particles were introduced individu-
ally into the system, they started to form clusters as contact was
established. This phenomenon can be observed by examining the tem-
poral progress of fine-fine contacts at early stages of the mixing, as
shown in Figure 7(A). The number of interparticle contacts of fines
increased sharply after the vibration started, and it decreased as the
mixing progressed due to the breakage of clusters. Compared to the
drug agglomerates, these clusters were weaker, more irregular in
shape, and had a broader size distribution (Figure 7(B)). At the peak of
the contact number, the mixture contained a few large and free clus-
ters, consisting of 40–100 primary fine particles, while at the comple-
tion of mixing, the fine particles were in smaller clusters and attached
to the carriers.
However, a comparatively lower breakage rate for drug agglomer-
ates in a ternary system does not necessarily indicate a poorer degree
of mixing for such systems. An assessment of drug particle distribu-
tion over the carriers revealed that, in the final state of mixing, all the
drug particles had adhered onto the carrier surface, although in differ-
ent forms. This difference can be attributed to the contrast between
forming a monolayer or a multilayer distribution of drugs over carriers,
and it was studied by exploring the number of drug particles directly
attached to a carrier particle.
Figure 8 shows the number of carrier-drug direct contacts for
the binary and ternary systems. Normalization was done after
dividing each value by the total number of drug particles (i.e. 900).
The difference in the offset of the two graphs, that is, at the begin-
ning of mixing, is associated with the deposition of drug particles
over the fines that are attached to the carriers in the ternary sys-
tem. Once the mixing of the binary mixture was completed, 97% of
all drug particles had been spread over the carrier particles. For the
ternary system, a lower percentage of drugs (85%) had directly
adhered to the carriers. This disparity signifies that, contrary to the
binary system, the drug particles in the ternary system are more
likely to attach to carriers in the form of small aggregates. This
observation suggests a possible advantage of ternary formulation
in aerosolization performance, similar to the assumptions behind
the agglomeration theory.
A more intriguing matter is the role of fine particles in hindering
the breakage of drug agglomerates. DEM results showed that, in the
course of mixing, the average kinetic energy of carrier particles was
F IGURE 9 Oscillation of the mean total
kinetic energy of carrier particles during
mixing in binary and ternary systems. The
inner figure shows the differences of
carrier-carrier and carrier-wall collision
rates between the binary and ternary
systems [Color figure can be viewed at
wileyonlinelibrary.com]
F IGURE 10 Distribution of adhesive force for carrier-drug and
carrier-fine contacts at the completion of ternary mixing. The graph
suggests that there is no preference for saturation of carrier active
sites by either drug or fine particles [Color figure can be viewed at
wileyonlinelibrary.com]
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alike for both systems, however, the rate of particle-particle and
particle-wall collision for carriers was significantly lower in the pres-
ence of fine particles (Figure 9). Analogous to what the buffer theory
suggests, it was observed here that the fines reduced carrier particle
collisions and, thus, protected drug particles from impact. Since the
agglomerate breakage in adhesive mixing is governed by continuous
collision and friction between coarse particles and drugs,44,45 the
buffer effect of fines prevents further disintegration of drug
agglomerates.
It is critical to emphasize that the role of fine particles in buffer
theory is more subtle than what is described here. A close examina-
tion of “fine lactose fines” (FLF) similar in size to the micronized drug,
and “coarse lactose fines” (CLF) twice the size of micronized drug
reveals that fine excipient particles act as a buffer that diminishes the
impact on drugs if they are larger than a certain size.46 Therefore, one
must be cautious not to draw a general conclusion on the effect of
added fine particles without further parameter variations.
4.2 | Assessment of active site theory
Once the mixing was completed, the adhesive contact between
carrier-drug and carrier-fine was determined in order to identify possi-
ble differences in attachment pattern. The adhesion properties,
TABLE 2 Critical fine particle attributes for each simulation case
Case number Fine particle size (μm) Fine particle loading ratio (%) Number of fine particles
Ternary I 5 5.7 700
Ternary II 5 12.2 1500
Ternary III 3 5.7 3241
Ternary IV 7 5.7 255
F IGURE 11 Size distribution of drug
agglomerates after 0.45 s of adhesive
mixing. As the loading ratio of fines
increases, the surviving agglomerates
become larger due to inefficient breakage
[Color figure can be viewed at
wileyonlinelibrary.com]
F IGURE 12 Cumulative kinetic energy (KE) of coarse particles in three systems, decomposed into translational and rotational components.
Due to the cohesion of fine particles, the particles assembly is lumped together, and their relative rotation decreases significantly [Color figure
can be viewed at wileyonlinelibrary.com]
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including the contact force and local contact position for each particle,
of the carrier surface were obtained, and the information is displayed
in Figure 10 as a comparative probability distribution of adhesion
forces. This suggests that, if the active site theory is at work, the car-
rier sites with lower activity will be covered by drug particles (left tail
of the distribution), and the highly active sites of the carrier will be
occupied by fine particles (right tail of the distribution). Figure 10
shows the distribution of the average adhesive contact force; the
carrier-drug and carrier-fine contacts are distinguished by two colors.
It can be seen in the figure that these two distributions are closely
matched, implying that the speculative competition between drug and
fine particles to adhere onto carriers, as proposed by the active site
theory, is not evident in the present simulation. This finding is
supported by previous experimental observations that contradict the
active site theory: the insignificance of blending order on formulation
performance,5 the ability of drug particles to displace the fines from
their carrier binding sites,7 and the ambiguous effect of carrier particle
size on the FPF reported by Islam et al.47
4.3 | The effect of fines loading ratio
An intricate aspect of ternary DPI formulation is that the dispersion
performance relies on the attributes of the added fine particles,
including loading ratio and size. The effect of the first variable is
explored by simulating an additional ternary system (case II) with a
higher percentage of added fine lactose (12.2% w/w equivalent to
1500 particles, Table 2). Analogous to the behavior at transition from
binary to ternary formulation, the breakage of drug agglomerates was
further suppressed at a higher loading ratio of fine particles. Compar-
ing the size distribution of drug agglomerates in the three systems, as
shown in Figure 11, it can be seen that as more fines are introduced
into the system, drug agglomerate breakage slows down, and the sur-
viving agglomerates become larger. This behavior results in poor
mixing because the drug particles do not distribute equally among car-
rier particles.
While the addition of 5.7% w/w fine particles into the binary sys-
tem was found to have a negligible effect on the kinetic energy of car-
rier particles, increasing the mass fraction of fines to 12.2% imposed a
noticeable effect on the total kinetic energy. Figure 12 shows the
cumulative kinetic energy of carrier particles for three adhesive mixing
systems. The translational and rotational components of the kinetic
energy are displayed separately. A major change that ensued from the
excess of fine particles is the significant decrease in the rotational
kinetic energy of coarse particles. This behavior is attributed to the
aggregation of coarse particles due to the cohesion of fine particles
and the resultant constraint on the dynamic behavior of the carriers.
The slow breakage rate for drug agglomerates in the ternary system
of 12.2% w/w fines can also be explained in terms of inefficient
energy transition to the drug particles due to the collective motion of
coarse particles and lack of interparticle collisions.
This phenomenon has been discussed by Shur et al11 in the
context of the aerosolization process, wherein the cohesion of
fines has been observed to increase the tensile strength of the
entire powder bed, and therefore, the particles move as a plug.
Those authors have argued that this behavior is in favor of the dis-
persion process because the cohesion of fines shifts the MFV.
However, they have not explained how the dispersion enhance-
ment is therapeutically achieved if the expiratory flow rate is
obstructed, as is normally the case with patients suffering from
chronic respiratory diseases.
4.4 | The effect of fine particle size
There are few experimental works on the role of fine particle size on
the performance of DPI ternary formulation. Examination of fine parti-
cle size from 3 up to 45 μm2,48,49 have shown that the greatest FPF of
Dfine=7 μm
Dfine=3 μm
F IGURE 13 Temporal decay in the average coordinate number of drug particles for ternary systems with different fine particle size. The
particle snapshots after 0.5 s of simulation for fine particle sizes of 7 and 3 μm are shown on the right side [Color figure can be viewed at
wileyonlinelibrary.com]
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drug is achieved when lactose fine particle with the median diameter
of 5.52 or 7.949 μm is used. It has been reported that very small fine
particles tend to aggregate and progressively occupy the carrier's sur-
face, and very large fine particles act as secondary carriers.
While the influence of fine particles size was briefly discussed in
the context of validity of buffer theory, further simulations are
required to elucidate the effect of this variable. For this purpose, two
supplementary simulations were conducted (cases III and IV in
Table 2). These simulations correspond to fine particle sizes of 3 and
7 μm with similar loading ratio of 5.7%.
Evaluation of contact number between mixture components
was used to scrutinize the mixing mechanism over time. The
behavior of average coordination number of drug particle over
time showed that large fine particles hinder the agglomerate
breakage significantly (Figure 13). Moreover, the size distribution
of drug agglomerates demonstrates that, as the fine particle diam-
eter increases, the size of surviving drug agglomerates increases
progressively. This result emphasizes that if the fine particles are
large enough, they create a shelter for drug agglomerates against
complete disintegration. Besides the sheltering effect, it is crucial
to notice that larger fine particles have greater adhesive contact
force (Equation 5), which results in constraint on the dynamic
behavior of the carriers. The aggregation of coarse particles due to
the cohesion of fines was recognized by a significant decline in the
rotational kinetic energy of carrier particles in the formulation con-
sisting of large fine particles (similar to Figure 12). Therefore, the
size ratio between fine and drug particles is a determinant of ter-
nary formulation performance.
The outcome of these simulations suggested that the extent of
drug and carrier particles adhesion is governed by two factors that act
in opposite directions. The first one is the number of drug particles in
the system, which was found to be inversely correlated to the size of
fine particle (more severe agglomerate breakage results in larger num-
ber of drug particles). The second factor is the available surface area
of the carrier particle for drug particle attachment, which was found
to decrease substantially when small fine particles in large number are
present in the system. The simulation results showed that the effect
of the first factor outweighs the second one, that is, the overall num-
ber of drug-carrier contacts was observed to increase when smaller
fine particles were introduced into the ternary formulation.
In addition to imposing an effect on the number of attached
drug particles, the fine particle size was observed to change the mag-
nitude of drug-carrier adhesion force. Analysis of variance showed a
significant decrease in contact force only for the system with 3 μm
fine particle (the size ratio of fine to drug equal to one) with the p-
value of 0.005. This behavior is not compatible with the experimen-
tal findings of Grasmeijer et al,46 primarily because the press-on
force has been the controlling adhesion mechanism in their work
and this effect was not incorporated into the existing DEM
framework.
4.5 | Evaluation of drug dispersion
Successive particle-wall collisions are regarded as a contributory
mechanism to the detachment of micronized drug particles from car-
riers in inhalers. In order to evaluate the performance of ternary for-
mulations compared to binary one, the dispersion behavior of each
blend was examined according to the following procedure. After the
mixing was finalized, the vibrating cell was removed from the simula-
tion domain and the particles assembly, under the influence of gravi-
tational force, were accelerated until they collided with a rigid wall in
the normal direction. With this configuration, particle dispersion at
five different velocities (corresponding to the average velocity of
carrier particles) was tested. The FPF was calculated by obtaining
the number of detached drug particles after the collision was com-
pleted. Earlier work by the authors50 has shown that similar wall-
impact test of an adhesive unit provides reliable information on the
drug dispersion performance in an inhaler. This fact arises from an
extremely high rate of wall collision experienced by the carriers and
the dominance of particle-wall collision energy over interparticle col-
lisions energy in the dispersion process.51 In addition, highly resolved
CFD–DEM simulation on a single adhesive unit by Cui and
Sommerfeld52 has shown that the probability of the fluid dynamic
detachment of micronized particle at the relative velocities that are
examined here is quite low, and wall-collision is the controlling
mechanism for dispersion.
Figure 14 shows the variation of drug FPF with impact velocity
for all the formulations wherein the FPF increases steadily with
impact velocity for all cases. Regarding the effect of fine loading ratio,
it can be observed that the lowest dispersion efficiency corresponds
to the binary formulation. This indicates the improved performance of
ternary formulations over binary ones. However, the highest effi-
ciency is observed for the ternary formulation with 5.7% of fine parti-
cles, which corroborate the findings that excess of fine particles does
not improve the drug dispersion. Concerning the role of fine particle
size, the dispersion efficiency is shown to depend on the size of lac-
tose fine particle. The emitted drug particle dose after collision (FPF)
is largest when 5 μm fine particle is included in the formulation. It is
important to stress that while Figure 14 provides valuable information
F IGURE 14 Dispersion of drug particles as a result of wall-
collision at different impact velocities [Color figure can be viewed at
wileyonlinelibrary.com]
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regarding the role of formulation variables in a ternary system, these
preliminary dispersion results can be subjective to this study and the
inherent shortcomings of DEM modeling. Assuredly, a more complex
simulation framework for testing the combined effect of flow- and
collision-induced dispersion and more elaborate parameter variations
are required to attain more conclusive results.
5 | CONCLUSION
DEM simulations were used to explore, in microscopic temporal and
spatial scales, the role of fines in the context of existing formulation
enhancement theories. A vibrating cell that contained a selected set
of pharmaceutical particles was used to model the adhesive mixing,
and a simple wall-collision test was designed to examine the disper-
sion performance of adhesive units. The central element of these sim-
ulations was to use a complex-shaped carrier particle rather than a
single sphere; a feature that led to a surface activity distribution simi-
lar to published experimental data.
For our limited set of particle properties, the results showed that
fine and drug particles occupy active carrier sites with similar tenden-
cies, and therefore, the active site theory was found implausible.
Investigating three different fine particle sizes indicated that larger
fine particles hinder the breakage of drug agglomerates more, either
by sheltering agglomerates against complete disintegration or by
adding to the cohesion of particle assembly and limiting the carriers'
motion. These mechanisms result in formation of drug multiplets over
the carrier surface. Similar behavior, that is, inefficient drug agglomer-
ate breakage, was observed by increasing the loading ratio of fine par-
ticles from 5.7% to 12.2%. The inclusion of cohesive fines added up
to the tensile strength of the particle assembly and restricted the rota-
tional motion of coarse particles.
For a deeper insight into the role of fines, the numerical results of
a preliminary collision-induced dispersion test were used to evaluate
each formulation. Considering all the simplification/assumptions that
lay behind our simulations, the FPF values revealed an intriguing result
that agreed with existing experimental evidences: the highest disper-
sion performance was neither attributed to largest fines nor greatest
loading ratio, instead an optimal set of system variables are required
to achieve the best formulation performance.
Although the current work provides insight into the complexity of
adhesive ternary mixing and the influence of some attributes, addi-
tional simulations must be carried out based on extensive parameter
variations to completely unravel the relevance and limitations of each
mechanism. This would mainly include the effect of cohesive-adhesive
balance, the particle size distribution of the mixing components, and
the mixing intensity in a ternary mixture.
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